Announced Tue, 29 Jul · 20:08 IST

Intimation of Earnings Conference Call for the quarter ended 30th June, 2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Fredun Pharmaceuticals has informed BSE that it will host an earnings conference call on Friday, 1st August 2025 at 11:00 a.m., following the announcement of its financial results for the quarter ended 30th June 2025. The intimation has been made under SEBI Listing Regulations. Dial-in numbers and a registration link via Chorus Call have been provided for participants. The disclosure is signed by Managing Director Fredun Medhora. No financial figures or results have been shared in this filing — it is purely a notice of the upcoming call.

Likely market impact

This is a routine procedural disclosure with no direct impact on shareholders or the stock price. Investors should watch for the Q1 FY26 financial results announcement and listen to the management call for any guidance or commentary on business performance.